Health
Results: 3217-3228 of 8221

SHL Medical opens new US$220 million manufacturing facility in the US to serve growing autoinjector market

ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights

Following a planned interim analysis in the PROCEED trial Lundbeck expands the dose finding to intravenous administration of Lu AG09222 in migraine prevention





